Mid-Tier Generic Company Facing Declining Revenues And Weak Business Outlook Due To The Generic Patent Cliff
Mid-Tier Generic Company Facing Declining Revenues And Weak Business Outlook Due To The Generic Patent Cliff
1 PagesThe Global 505(b)(2) Experts CamargoPharma.com | 9825 Kenwood Road Cincinnati, OH 45242 USA | (513) 561-3329 Case Study 5 Case Study 5: Mid-tier generic company facing declining revenues and weak business outlook due to the generic patent cliff. Challenge: Indian generic company tried to use its internal regulatory competencies to identify and develop drug candidates using the 505(b)(2) pathway with no success
